Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

INNOGEN-B

4.080
-0.130-3.09%
Volume:9.61M
Turnover:39.19M
Market Cap:1.86B
PE:-4.43
High:4.230
Open:4.215
Low:4.010
Close:4.210
52wk High:53.000
52wk Low:4.010
Shares:457.00M
HK Float Shares:420.29M
Volume Ratio:0.70
T/O Rate:2.29%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.922
ROE:-36.91%
ROA:-17.30%
PB:1.52
PE(LYR):-4.43
PS:12.15

Loading ...

OverviewCompanyNewsFilings

Company Profile

Company Name:
INNOGEN-B
Exchange:
SEHK
Establishment Date:
2014
Employees:
- -
Office Location:
Qiantan Times Square,21st floor,No. 399 Haiyang West Road,Pudong New District,Shanghai,China
Website:
http://www.innogenpharm.com
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Guangzhou Innogen Pharmaceutical Group Co Ltd is a China-based investment holding company principally engaged in the research, development and commercialisation of pharmaceutical products. The Company is primarily engaged in the commercialization of innovative, humanized, long-acting glucagon-like peptide-1 (GLP-1) receptor agonist. The Company is dedicated to developing therapies for diabetes and other metabolic diseases. The Company’s core product, Efsubaglutide Alfa (brand name: Diabegone), is used for the treatment of type 2 diabetes (T2D). The Company’s primary pipeline drug candidates include YN014, YN401, YN209, YN203, and YN202. The Company principally conducts its businesses in the domestic market.

Directors

Name
Position
Wang Qinghua
Chairman of the Board,Executive Director,Chairman of the Strategic and Development Committee,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
JIANG Fan
Executive Director,Member of the Strategic and Development Committee,Member of the Nomination Committee
XU Wen Jie
Executive Director,Member of the Strategic and Development Committee
HUANG Bing
Executive Director
Ho Kyung Shik
Director
HENG Lei
Director
TAO Wu Ping
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee
SONG Rui Lin
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee
CHEN Xiang Rong
Independent Director,Member of the Nomination Committee,Chairman of the Audit Committee

Shareholders

Name
Position
Wang Qinghua
General Manager
JIANG Fan
Vice General Manager,CFO,Board Secretary
XU Wen Jie
Vice General Manager
HUANG Bing
Vice General Manager,Other Senior Executives
YANG Dong Yan
Corporate Secretary
Mak Po Man Cherie
Corporate Secretary
JIN Jin
Other Senior Executives